Search Results - Heather A. Brandling‐Bennett
- Showing 1 - 3 results of 3
-
1
-
2
Mosaic Activating Mutations in FGFR1 Cause Encephalocraniocutaneous Lipomatosis by James T. Bennett, Tiong Yang Tan, Diana Alcantara, Martine Tétrault, Andrew E. Timms, Dana M. Jensen, Sarah Collins, Małgorzata J.M. Nowaczyk, Marjorie J. Lindhurst, Katherine Christensen, Stephen R. Braddock, Heather A. Brandling‐Bennett, Raoul C. M. Hennekam, Brian Hon‐Yin Chung, Anna Lehman, John Su, SuYuen Ng, David J. Amor, Jacek Majewski, Les Biesecker, Kym M. Boycott, William B. Dobyns, Mark O’Driscoll, Ute Moog, Laura M. McDonell
Published 2016Artigo -
3
Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelines by Elaine C. Siegfried, Lisa M. Arkin, Yvonne E. Chiu, Adelaide A. Hebert, Jeffrey P. Callen, Leslie Castelo‐Soccio, Dominic O. Co, Kelly M. Cordoro, Megan L. Curran, Austin Dalrymple, Carsten Flohr, Ken Gordon, Diane Hanna, Alan D. Irvine, Susan Kim, A. Yasmine Kirkorian, Irene Lara‐Corrales, Jill A. Lindstrom, Amy S. Paller, Melissa Reyes, Wendy Smith Begolka, Wynnis L. Tom, Abby S. Van Voorhees, Ruth Ann Vleugels, Lara Wine Lee, Olivia M. T. Davies, Heather A. Brandling‐Bennett
Published 2023Artigo
Search Tools:
Related Subjects
Medicine
Dermatology
Pathology
Adverse effect
Alternative medicine
Archaeology
Atopic dermatitis
Biology
Chemotherapy
Cyclophosphamide
Dosing
Environmental health
Evidence-based medicine
Family medicine
Fibroblast growth factor
Fibroblast growth factor receptor 1
Gene
Genetics
Geography
Intensive care medicine
Internal medicine
Law
Lipomatosis
MEDLINE
Methotrexate
Mosaic
Mutation
Off-label use
Pathogenesis
Pharmacology